Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 332 followers
Latest posts
Last updated about 14 hours ago
Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 30/03/2023, Revision: 15, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted)...
Human medicines European public assessment report (EPAR): Inhixa, enoxaparin sodium, Date of authorisation: 15/09/2016, Revision: 32, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Inhixa, enoxaparin sodium, Date of...
Human medicines European public assessment report (EPAR): Vaxneuvance, pneumococcal polysaccharide conjugate vaccine (adsorbed), Date of authorisation: 13/12/2021, Revision: 9, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Vaxneuvance, pneumococcal polysaccharide conjugate vaccine...
Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34- cells, non-expanded,dorocubicel, Date of authorisation: 25/08/2025, Revision: 3, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34-...
Human medicines European public assessment report (EPAR): Elocta, efmoroctocog alfa, Date of authorisation: 18/11/2015, Revision: 16, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Elocta, efmoroctocog alfa, Date of...
Human medicines European public assessment report (EPAR): Trodelvy, sacituzumab govitecan, Date of authorisation: 22/11/2021, Revision: 6, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Trodelvy, sacituzumab govitecan, Date of...
Questions and answers on Article 20 non-pharmacovigilance procedures
about 16 hours ago
Questions and answers on Article 20 non-pharmacovigilance procedures
Questions and answers: Article 13 referral procedures
about 16 hours ago
Questions and answers: Article 13 referral procedures
Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Date of authorisation: 22/03/2017, Revision: 37, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Date of authorisation...
Questions and answers on Article 13 referral procedures
about 17 hours ago
Questions and answers on Article 13 referral procedures
Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 40, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation...